ESSA Pharma's total assets for Q1 2025 were $122.63M, a decrease of -4.28% from the previous quarter. EPIX total liabilities were $3.87M for the fiscal quarter, a 10.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.